Fascinatingly, TRIM26 was found to stabilize SOX2 protein and enhance its oncogenic activity in glioblastoma via its C-terminal PRYSPRY domain without engaging its Ring domain and E3 ligase activity (11). The gene discussed is SOX2; the disease is glioblastoma.